The DOI matches its Crossref record; 271 of the 271 references it cites were found in a registry or an index.
Antifungal Resistance and New Strategies to Control Fungal Infections
Open accessAbstract
Despite improvement of antifungal therapies over the last 30 years, the phenomenon of antifungal resistance is still of major concern in clinical practice. In the last 10 years the molecular mechanisms underlying this phenomenon were extensively unraveled. In this paper, after a brief overview of currently available antifungals, molecular mechanisms of antifungal resistance will be detailed. It appears that major mechanisms of resistance are essential due to the deregulation of antifungal resistance effector genes. This deregulation is a consequence of point mutations occurring in transcriptional regulators of these effector genes. Resistance can also follow the emergence of point mutations directly in the genes coding antifungal targets. In addition we further describe new strategies currently undertaken to discover alternative therapy targets and antifungals. Identification of new antifungals is essentially achieved by the screening of natural or synthetic chemical compound collections. Discovery of new putative antifungal targets is performed through genome-wide approaches for a better understanding of the human pathogenic fungi biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–271 of 271
Perea, S. H., Lopez-Ribot, J. L., Wickes, B. L., Kirkpatrick, W. R., Dib, O. P., Bachmann, S. P., Keller, S. M., Martínez, M., & Patterson, T. F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1695-1703.2002 · Cited by 99
MacCallum, D. M., Coste, A., Ischer, F., Jacobsen, M. D., Odds, F. C., & Sanglard, D. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01645-09 · Cited by 98
Self-citationClinical relevance of mechanisms of antifungal drug resistance in yeasts
Sanglard, D. (2002) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(02)72842-5 · Cited by 98
Mutational Analysis of Flucytosine Resistance in Candida glabrata
Edlind, T. D., & Katiyar, S. K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00605-10 · Cited by 94
CaNdt80 Is Involved in Drug Resistance in Candida albicans by Regulating CDR1
Chen, C.-G., Yang, Y.-L., Shih, H., Su, C.-L., & Lo, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4505-4512.2004 · Cited by 94
Role of Ndt80p in Sterol Metabolism Regulation and Azole Resistance in Candida albicans
Sellam, A., Tebbji, F., & Nantel, A. (2009) · Eukaryotic Cell · doi:10.1128/ec.00074-09 · Cited by 91
Marco, F., Pfaller, M. A., Messer, S. A., & Jones, R. N. (1998) · Medical Mycology · doi:10.1080/02681219880000691 · Cited by 90
Wu, W., Pujol, C., Lockhart, S. R., & Soll, D. R. (2005) · Genetics · doi:10.1534/genetics.104.033167 · Cited by 88
Oakley, K. L., Moore, C. B., & Denning, D. W. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2726 · Cited by 88
Potoski, B. A., & Brown, J. E. (2002) · Clinical Infectious Diseases · doi:10.1086/343746 · Cited by 88
The Central Role of PDR1 in the Foundation of Yeast Drug Resistance
Fardeau, V., Lelandais, G., Oldfield, A., Salin, H., Lemoine, S., Garcia, M., Tanty, V., Crom, S. L., Jacq, C., & Devaux, F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610197200 · Cited by 82
Bader, T., Schröppel, K., Bentink, S., Agabian, N., Köhler, G., & Morschhäuser, J. (2006) · Infection and Immunity · doi:10.1128/iai.00142-06 · Cited by 81
Milhaud, J., Ponsinet, V., Takashi, M., et al. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00416-3 · Cited by 81
Coste, A. T., Crittin, J., Bauser, C., Rohde, B., & Sanglard, D. (2009) · Eukaryotic Cell · doi:10.1128/ec.00069-09 · Cited by 79
Self-citationSchubert, S., Rogers, P. D., & Morschhäuser, J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00740-08 · Cited by 79
CHEMOTHERAPEUTIC ACTIVITY OF 5-FLUOROCYTOSINE.
Grunberg, E., Titsworth, E. H., & Bennett, M. A. (1963) · PubMed · Cited by 78
ANTIFUNGAL SUSCEPTIBILITY TESTING
Pfaller, M. A., & Yu, W. L. (2001) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70192-6 · Cited by 77
Flucytosine Monotherapy for Cryptococcosis
Hospenthal, D. R., & Bennett, J. E. (1998) · Clinical Infectious Diseases · doi:10.1086/514669 · Cited by 76
Echinocandin pharmacodynamics: review and clinical implications
Pound, M. W., Townsend, M. L., & Drew, R. H. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq081 · Cited by 76
Discovery of a Novel Class of Orally Active Antifungal β-1,3- d -Glucan Synthase Inhibitors
Walker, S. S., Xu, Y., Triantafyllou, I., Waldman, M. F., Mendrick, C., Brown, N., Mann, P., Chau, A., Patel, R., Bauman, N., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00432-11 · Cited by 75
Clinical use of systemic antifungal agents.
Benson, J., & Nahata, M. C. (1988) · PubMed · Cited by 75
Eucker, J., Sezer, O., Graf, B., & Possinger, K. (2001) · PubMed · Cited by 75
Molecular Mechanisms of Itraconazole Resistance in Candida dubliniensis
Pinjon, E., Moran, G. P., Jackson, C. J., Kelly, S. L., Sanglard, D., Coleman, D. C., & Sullivan, D. J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2424-2437.2003 · Cited by 74
Resistant P45051A1 activity in azole antifungal tolerant Cryptococcus neoformans from AIDS patients
Lamb, D. C., Corran, A. J., Baldwin, B. C., Kwon‐Chung, J., & Kelly, S. L. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00684-2 · Cited by 73
Boogaerts, M., Maertens, J. A., van der Geest, R., Bosly, A., Michaux, J., Hoof, A. V., Cleeren, M., Woestenborghs, R. J. H., & Beule, K. D. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.981-985.2001 · Cited by 72
Miyazaki, Y., Geber, A., Miyazaki, H., Falconer, D., Parkinson, T., Hitchcock, C., Grimberg, B., Nyswaner, K., & Bennett, J. E. (1999) · Gene · doi:10.1016/s0378-1119(99)00263-2 · Cited by 71
Rognon, B., Kozovska, Z., Coste, A. T., Pardini, G., & Sanglard, D. (2006) · Microbiology · doi:10.1099/mic.0.29277-0 · Cited by 71
Self-citationFungal Biofilms and Antimycotics
Chandra, J., Zhou, G., & Ghannoum, M. A. (2005) · Current Drug Targets · doi:10.2174/138945005774912762 · Cited by 70
Cota, J. M., Grabinski, J. L., Talbert, R. L., Burgess, D. S., Rogers, P. D., Edlind, T. D., & Wiederhold, N. P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01542-07 · Cited by 69
Nagi, M., Nakayama, H., Tanabe, K., Bard, M., Aoyama, T., Okano, M., Higashi, S., Ueno, K., Chibana, H., Niimi, M., et al. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01470.x · Cited by 68
Function of Candida glabrata ABC transporter gene, PDH1
Izumikawa, K., Kakeya, H., Tsai, H., Grimberg, B., & Bennett, J. E. (2003) · Yeast · doi:10.1002/yea.962 · Cited by 67
Hikkel, I., Lucau‐Danila, A., Delaveau, T., Marc, P., Devaux, F., & Jacq, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208549200 · Cited by 64
Epp, E., Vanier, G., Harcus, D., Lee, A. Y., Jansen, G., Hallett, M., Sheppard, D. C., Thomas, D. Y., Munro, C. A., Mullick, A., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000753 · Cited by 61
Vandeputte, P., Ischer, F., Sanglard, D., & Coste, A. T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026962 · Cited by 61
Self-citationRiggle, P. J., & Kumamoto, C. A. (2006) · Eukaryotic Cell · doi:10.1128/ec.00243-06 · Cited by 61
Large-Scale Gene Disruption Using the UAU1 Cassette
Nobile, C. J., & Mitchell, A. P. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-151-6_17 · Cited by 60
Epp, E., Walther, A., Lépine, G., Leon, Z., Mullick, A., Raymond, M., Wendland, J., & Whiteway, M. S. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.07038.x · Cited by 59
Molecular Mechanisms of Resistance to 5-Fluorocytosine in Laboratory Mutants of Candida glabrata
Vandeputte, P., Pineau, L., Larcher, G., Noel, T., Brèthes, D., Chabasse, D., & Bouchara, J.-P. (2011) · Mycopathologia · doi:10.1007/s11046-010-9342-1 · Cited by 55 · cited 1×
“This increase in activity of the de novo pyrimidine biosynthetic pathway is reflected by an increased expression of the CDC21 gene, whose product is inhibited by 5FC [205].”
BackgroundSelf-citationOliver, B. G., Song, J. L., Choiniere, J. H., & White, T. C. (2007) · Eukaryotic Cell · doi:10.1128/ec.00331-06 · Cited by 53 · cited 1×
“albicans ERG11 (Table 3) [215, 216].”
Karnani, N., Gaur, N. A., Jha, S., Puri, N., Krishnamurthy, S., Goswami, S. K., Mukhopadhyay, G., & Prasad, R. (2004) · Yeast · doi:10.1002/yea.1067 · Cited by 53
Chamilos, G., Nobile, C. J., Bruno, V. M., Lewis, R. E., Mitchell, A. P., & Kontoyiannis, D. P. (2009) · The Journal of Infectious Diseases · doi:10.1086/599363 · Cited by 53
Ribeiro, M. A., & Paula, C. R. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.04.019 · Cited by 52
TheCandida dubliniensis CdCDR1Gene Is Not Essential for Fluconazole Resistance
Moran, G. P., Sullivan, D. J., Morschhäuser, J., & Coleman, D. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2829-2841.2002 · Cited by 50
Mogavero, S., Tavanti, A., Senesi, S., Rogers, P. D., & Morschhäuser, J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01467-10 · Cited by 49
Warn, P. A., Sharp, A., Guinea, J., & Denning, D. W. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh153 · Cited by 49
Failure of Ketoconazole in Cryptococcal Meningitis
Perfect, J. R., Durack, D. T., Hamilton, J. D., & Gallis, H. A. (1982) · JAMA · doi:10.1001/jama.1982.03320490047035 · Cited by 49
Microreview of Pityriasis versicolor and Malassezia species
Morishita, N., & Sei, Y. (2006) · Mycopathologia · doi:10.1007/s11046-006-0081-2 · Cited by 47
Antifungal Drug Discovery through the Study of Invertebrate Model Hosts
Pukkila-Worley, R., Holson, E. B., Wagner, F. F., & Mylonakis, E. E. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788186237 · Cited by 47
Coste, A. T., Ramsdale, M., Ischer, F., & Sanglard, D. (2008) · Microbiology · doi:10.1099/mic.0.2007/016063-0 · Cited by 46
Self-citationPuri, N., Krishnamurthy, S., Habib, S., Hasnain, S. E., Goswami, S. K., & Prasad, R. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb08798.x · Cited by 45
The Possible Mechanism of Action of Ciclopirox Olamine in the Yeast Saccharomyces cerevisiae
Leem, S., Park, J., Kim, I.-S., Chae, J.-Y., Sugino, A., & Sunwoo, Y. (2003) · Molecules and Cells · doi:10.1016/s1016-8478(23)13707-1 · Cited by 44
Large-scale gene function analysis in Candida albicans
Bruno, V. M., & Mitchell, A. P. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.02.002 · Cited by 44
Temperature affects the susceptibility of Cryptococcus neoformans biofilms to antifungal agents
Pettit, R. K., Repp, K. K., & Hazen, K. C. (2009) · Medical Mycology · doi:10.1080/13693780903136879 · Cited by 44
Isolation and analysis of ketoconazole resistant mutants ofSaccharomyces cerevisiae
Watson, P. F., Rose, M. E., & Kelly, S. L. (1988) · Medical Mycology · doi:10.1080/02681218880000231 · Cited by 43
Hamal, P., Ostřanský, J., Dendis, M., Horváth, R., Růžička, F., Buchta, V., Vejsová, M., Sauer, P., Hejnar, P., & Raclavský, V. (2008) · Medical Mycology · doi:10.1080/13693780802078180 · Cited by 43
Hiller, D., Stahl, S., & Morschhäuser, J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00196-06 · Cited by 42
EUCAST breakpoints for antifungals
Rodrı́guez-Tudela, J. L., Arendrup, M. C., Cuenca‐Estrella, M., Donnelly, J. P., & Lass‐Flörl, C. (2010) · Drug News & Perspectives · doi:10.1358/dnp.2010.23.2.1400855 · Cited by 41
Pinjon, E., Jackson, C. J., Kelly, S. L., Sanglard, D., Moran, G. P., Coleman, D. C., & Sullivan, D. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1312-1318.2005 · Cited by 40
Yang, X., Talibi, D., Weber, S., Poisson, G., & Raymond, M. (2001) · Yeast · doi:10.1002/yea.770 · Cited by 37
Gaur, N. A., Puri, N., Karnani, N., Mukhopadhyay, G., GOSWAMI, S., & PRASAD, R. (2003) · FEMS Yeast Research · doi:10.1016/s1567-1356(03)00204-6 · Cited by 36
SAR studies of pyridazinone derivatives as novel glucan synthase inhibitors
Zhou, G., Ting, P. C., Aslanian, R. G., Cao, J., Kim, D. W., Kuang, R., Lee, J. F., Schwerdt, J. H., Wu, H., Herr, R. J., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.03.083 · Cited by 34
Drug Resistance in Candida albicans and Candida glabrataa
Kerridge, D., FASOLI, M., & Wayman, F. J. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb40410.x · Cited by 30
Wang, J., Yang, Y.-L., Wu, C.-J., Ouyang, K. J., Tseng, K., Chen, C.-G., Wang, H., & Lo, H. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46650-0 · Cited by 26
Shen, H., An, M., Wang, D. J., Xu, Z. Q., Zhang, J., Gao, P., Cao, Y., Cao, Y., & Jiang, Y. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.68 · Cited by 25
Gaur, N. A., Manoharlal, R., Saini, P., Prasad, T., Mukhopadhyay, G., Hoefer, M., Morschhäuser, J., & Prasad, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.113 · Cited by 25
Do Aspergillus Species Produce Biofilm?
Chandrasekar, P. H., & Manavathu, E. K. (2008) · Future Microbiology · doi:10.2217/17460913.3.1.19 · Cited by 25
The synthesis and structure–activity relationship of pyridazinones as glucan synthase inhibitors
Ting, P. C., Kuang, R., Wu, H., Aslanian, R. G., Cao, J., Kim, D. W., Lee, J. F., Schwerdt, J. H., Zhou, G., Wainhaus, S. B., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.058 · Cited by 21
Williams, K. M., Duffield, A. M., Christopher, R. K., & Finlayson, P. J. (1981) · Journal of Mass Spectrometry · doi:10.1002/bms.1200080410 · Cited by 19
Dryden, M. W., & Payne, P. A. (2005) · PubMed · Cited by 14
Eucker, J., Sezer, O., Graf, B., & Possinger, K. (2001) · Mycoses · doi:10.1046/j.1439-0507.2001.00656.x · Cited by 11
Cited by
Campoy, S., & Adrio, J. L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.019 · Cited by 511
Candidiasis and Mechanisms of Antifungal Resistance
Bhattacharya, S., Sae-Tia, S., & Fries, B. C. (2020) · Antibiotics · doi:10.3390/antibiotics9060312 · Cited by 474
Spampinato, C., & Leonardi, D. (2013) · BioMed Research International · doi:10.1155/2013/204237 · Cited by 411
Biofilm of Candida albicans : formation, regulation and resistance
Pereira, R., Santos Fontenelle, R. O., Brito, E. H. S., & Morais, S. M. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.14949 · Cited by 368
Paulussen, C., Hallsworth, J. E., Álvarez‐Pérez, S., Nierman, W. C., Hamill, P. G., Blain, D., Rediers, H., & Lievens, B. (2017) · Microbial Biotechnology · doi:10.1111/1751-7915.12367 · Cited by 334
Metadata
- Authors
- Vandeputte, P., Ferrari, S., & Coste, A. T.
- Venue
- International Journal of Microbiology
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-26
- ISSN
- 1687-918X (ISSN-L)
- 1687-9198
- OpenAlex
- W2070654910
- Cited by
- 505
- References
- 271
- FWCI
- 11.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.